Large trials randomising tens of thousands of patients would be required to accurately detect an effect of GLP-1RA on SIS risk
Endocrinology 146 (4), 17641771
Weight loss medications may make you lose your appetite and cravings for food, but they wont touch the underlying root causes of why you turned to food to soothe
39 Although GLP-1RAs continue to be promising therapies for T2D, their long-term efficacy for weight loss after halting treatment should be further improved
For instance, semaglutide has been approved and is being researched for indications including obesity, T2DM, reducing cardiovascular risk, chronic kidney disease, NAFLD, and AD, indicating that the development of new indications could provide new growth opportunities for GLP-1 drugs
GLP-1 Precautions for Using the GLP-1 program The GLP-1 program works by assisting the pancreas in regulating and reducing blood sugar levels